• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 234-248 of 1,124 results

2008 Exhibit: EX2008 Claim Construction Order, In re Ozempic Semaglutide Paten...

Document IPR2024-00009, No. 2008 Exhibit - EX2008 Claim Construction Order, In re Ozempic Semaglutide Patent Litigation, No 22 MD 03038 CFC, Dkt 148 D Del July 25, 2023 (P.T.A.B. Jan. 26, 2024)

cite Cite Document
Analyze

2006 Exhibit: EX2006 Scheduling Order, Novo Nordisk Inc v Rio Biopharms, Inc, No...

Document IPR2024-00009, No. 2006 Exhibit - EX2006 Scheduling Order, Novo Nordisk Inc v Rio Biopharms, Inc, No 122 cv 00294 CFC, Dkt 22 D Del (P.T.A.B. Jan. 26, 2024)

cite Cite Document
Analyze

2011 Exhibit: EX2011 US Patent No 8,114,833

Document IPR2024-00009, No. 2011 Exhibit - EX2011 US Patent No 8,114,833 (P.T.A.B. Jan. 26, 2024)

cite Cite Document
Analyze

1007 Exhibit: Declaration of Paul Dalby, PhD

Document IPR2024-00009, No. 1007 Exhibit - Declaration of Paul Dalby, PhD (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1062 Exhibit: Zarin, The ClinicalTrialsgov Results Data, 364 NEW ENGL J MED 852...

Document IPR2024-00009, No. 1062 Exhibit - Zarin, The ClinicalTrialsgov Results Data, 364 NEW ENGL J MED 852 2011 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1096 Exhibit: CV of Dr Maureen M Donovan

Document IPR2024-00009, No. 1096 Exhibit - CV of Dr Maureen M Donovan (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1034 Exhibit: US Patent No 6,268,343

Document IPR2024-00009, No. 1034 Exhibit - US Patent No 6,268,343 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1023 Exhibit: Drucker, Enhancing Incretin Action 26 DIABETES CARE 2929 2003

Document IPR2024-00009, No. 1023 Exhibit - Drucker, Enhancing Incretin Action 26 DIABETES CARE 2929 2003 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1088 Exhibit: Markman Hearing Transpt Re OzempicNo 22 MD 3038 D Del July 13, ...

Document IPR2024-00009, No. 1088 Exhibit - Markman Hearing Transpt Re OzempicNo 22 MD 3038 D Del July 13, 2023 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1047 Exhibit: Tamimi, Drug Development, 13 NEPHRON CLINICAL PRACTICE c125...

Document IPR2024-00009, No. 1047 Exhibit - Tamimi, Drug Development, 13 NEPHRON CLINICAL PRACTICE c125 2009 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1064 Exhibit: Monami, Effects of Glucagon Like Peptide 1 EXPER DIABETES RSCH...

Document IPR2024-00009, No. 1064 Exhibit - Monami, Effects of Glucagon Like Peptide 1 EXPER DIABETES RSCH 1 2012 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1039 Exhibit: Victoza, PHYSICIANS’ DESK REFERENCE 65th ed 2010

Document IPR2024-00009, No. 1039 Exhibit - Victoza, PHYSICIANS’ DESK REFERENCE 65th ed 2010 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1081 Exhibit: Ozempic prescribing information Oct 2022

Document IPR2024-00009, No. 1081 Exhibit - Ozempic prescribing information Oct 2022 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1042 Exhibit: WO 9111457

Document IPR2024-00009, No. 1042 Exhibit - WO 9111457 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1036 Exhibit: Mojsov, Insulinotropin,79 J CLINICAL INVESTIGATION 616 1987

Document IPR2024-00009, No. 1036 Exhibit - Mojsov, Insulinotropin,79 J CLINICAL INVESTIGATION 616 1987 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 16 17 18 19 20 ... >>